2. The Fifth Schedule to the Misuse of Drugs Act is amended —(a) | by deleting items (1) to (18) of paragraph 1 and substituting the following items: “(1) | 2-Amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one (also known as bk-2C-B) and its bromo and dimethoxy positional isomers in the phenyl ring |
|
(2) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (also known as MAB-CHMINACA) |
|
(3) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as 5-Fluoro-ADB-PINACA) and its fluoro positional isomers in the pentyl group |
|
(4) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (also known as ADB-PINACA) |
|
(5) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-chloropentyl)-1H-indazole-3-carboxamide (also known as 5-Chloro-AB-PINACA) and its chloro positional isomers in the pentyl group |
|
(6) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (also known as AB-CHMINACA) |
|
(7) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as 5-Fluoro-AB-PINACA) and its fluoro positional isomers in the pentyl group |
|
(8) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (also known as AB-PINACA) |
|
(9) | N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as PX-2) and its fluoro positional isomers in the pentyl group |
|
(10) | N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (also known as PX-1) and its fluoro positional isomers in the pentyl group |
|
(11) | 1-(1-Benzofuran-5-yl)-N-ethylpropan-2-amine (also known as 5-EAPB) and its 4-yl, 6-yl and 7-yl isomers |
|
(12) | 2-(2,5-Dimethoxyphenyl)ethanamine (also known as 2C-H) and its dimethoxy positional isomers in the phenyl ring |
|
(14) | [1-(5-Fluoropent-1-yl)-1H-benzimidazol-2-yl](naphthalen-1-yl)methanone (also known as FUBIMINA) and its fluoro positional isomers in the pentyl group |
|
(15) | [1-(5-Fluoropent-1-yl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (also known as THJ-2201) and its fluoro positional isomers in the pentyl group |
|
(16) | 1-(1H-Indol-5-yl)propan-2-amine (also known as 5-IT) and its 4-yl, 6-yl and 7-yl isomers |
|
(17) | 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (also known as 2C-I) and its dimethoxy and iodo positional isomers in the phenyl ring |
|
(18) | Methyl 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (also known as MDMB-CHMINACA) |
|
(19) | Methyl 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3-methylbutanoate (also known as MA-CHMINACA) |
|
(20) | Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoate (also known as 5-Fluoro-AMB) and its fluoro positional isomers in the pentyl group”; and |
|
|
|
| (b) | by inserting, immediately after paragraph 1, the following paragraph:“2. | Any compound (other than serotonin or a Class A drug) structurally derived from 2-(1H-indol-3-yl)ethanamine (also known as tryptamine) by modification in any of the following ways: |
|
(a) | substitution at the nitrogen atom of the side chain to any extent with alkyl or alkenyl substituents, or by inclusion of only the nitrogen atom of the side chain in a cyclic structure; |
|
(b) | substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents; |
|
(c) | substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, hydroxy, thioalkyl, alkylenedioxy or halide substituents; |
|
(d) | substitution at the 2-position of the tryptamine ring system with an alkyl substituent, |
|
| including any acyl derivative, ether, salt or stereoisomeric form of any such compound, any preparation or product containing any such compound, and the following examples of such a compound: |
|
(1) | 4-Acetoxy-N,N-diisopropyltryptamine (also known as 4-Acetoxy-DiPT or 4-AcO-DiPT); |
|
(2) | 4-Acetoxy-N,N-dimethyltryptamine (also known as 4-Acetoxy-DMT or 4-AcO-DMT); |
|
(3) | 5-Benzyloxytryptamine; |
|
(4) | 5-Bromo-N,N-dimethyltryptamine (also known as 5-Bromo-DMT); |
|
(6) | 5-Chloro-α-methyltryptamine (also known as 5-Chloro-AMT); |
|
(8) | N,N-Diallyltryptamine; |
|
(9) | N,N-Diisopropyltryptamine; |
|
(10) | N,N-Dipropyltryptamine; |
|
(11) | 5-Fluoro-N,N-dimethyltryptamine (also known as 5-Fluoro-DMT); |
|
(12) | 5-Fluoro-α-methyltryptamine (also known as 5-Fluoro-AMT); |
|
(14) | 4-Hydroxy-N,N-diethyltryptamine (also known as 4-Hydroxy-DET or 4-HO-DET); |
|
(15) | 4-Hydroxy-N,N-diisopropyltryptamine (also known as 4-Hydroxy-DiPT or 4-HO-DiPT); |
|
(16) | 4-Hydroxy-N-methyl-N-ethyltryptamine (also known as 4-Hydroxy-MET or 4-HO-MET); |
|
(17) | 4-Hydroxy-N-methyl-N-isopropyltryptamine (also known as 4-Hydroxy-MiPT or 4-HO-MiPT); |
|
(18) | 4-Hydroxy-α-methyltryptamine (also known as 4-Hydroxy-AMT or 4-HO-AMT); |
|
(19) | 5-Hydroxy-N-methyltryptamine (also known as 5-Hydroxy-NMT or 5-HO-NMT); |
|
(20) | 5-Methoxy-N,N-diallyltryptamine (also known as 5-Methoxy-DALT or 5-MeO-DALT); |
|
(21) | 5-Methoxy-N,N-diethyltryptamine (also known as 5-Methoxy-DET or 5-MeO-DET); |
|
(22) | 5-Methoxy-N,N-dipropyltryptamine (also known as 5-Methoxy-DPT or 5-MeO-DPT); |
|
(23) | 5-Methoxy-N-ethyl-N-isopropyltryptamine (also known as 5-Methoxy-EiPT or 5-MeO-EiPT); |
|
(24) | 5-Methoxy-N-ethyl-N-propyltryptamine (also known as 5-Methoxy-EPT or 5-MeO-EPT); |
|
(25) | 5-Methoxy-α-ethyltryptamine (also known as 5-Methoxy-AET or 5-MeO-AET); |
|
(26) | 5-Methoxy-N-methyl-N-isopropyltryptamine (also known as 5-Methoxy-MiPT or 5-MeO-MiPT); |
|
(27) | 5-Methoxy-α-methyltryptamine (also known as 5-Methoxy-AMT or 5-MeO-AMT); |
|
(28) | 5-Methoxy-N-methyltryptamine (also known as 5-Methoxy-NMT or 5-MeO-NMT); |
|
(29) | 4-Methyl-α-ethyltryptamine (also known as 4-Methyl-AET); |
|
(32) | N-Methyltryptamine.”. |
|
|
|
|
|